A quantitative GFP-based bioassay for the detection of HIV-1 Tat transactivation inhibitors

被引：24

作者：

Daelemans, D ^{[1
]}

De Clercq, E ^{[1
]}

Vandamme, AM ^{[1
]}

机构：

[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium

来源：

JOURNAL OF VIROLOGICAL METHODS | 2001年 / 96卷 / 02期

关键词：

HIV-1; Tat; GFP; bioassay;

D O I：

10.1016/S0166-0934(01)00330-5

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

The Tat function of the human immunodeficiency virus (HIV) represents an important target for the development of new anti-HIV drugs. A rapid, sensitive and simple bioassay was developed for the detection of HIV transactivation inhibitors. A reporter plasmid based on the expression of the green fluorescent protein (GFP) under control of the HIV-1 long terminal repeat (LTR) was constructed. This reporter gene can be quantified by simply measuring the fluorescence irradiated by GFP-producing cells, without the need of extraction procedures or enzymatic assays. Cells, stably expressing HIV-1 Tat protein, were transfected with this plasmid and the inhibitory effect of anti-Tat drugs was assessed by measuring the inhibition of fluorescence. Using this assay system the anti-transactivation activity of several known compounds was confirmed. This is the first HIV transactivation assay using GFP reporter gene in microtiter plates. The assay can be used for the detection and quantification of HIV trans activation, and for the high throughput evaluation of anti-trans activation drugs in different cellular backgrounds. (C) 2001 Elsevier Science B.V. All rights reserved.

引用

页码：183 / 188

页数：6

共 14 条

[1]

Baba M, 1998, MOL PHARMACOL, V53, P1097

[2]

CAPUTO A, 1990, J ACQ IMMUN DEF SYND, V3, P372

[3] S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation [J].

Daelemans, D ;

Esté, JA ;

Witvrouw, M ;

Pannecouque, C ;

Jonckheere, H ;

Aquaro, S ;

Perno, CF ;

De Clercq, E ;

Vandamme, AM .

MOLECULAR PHARMACOLOGY, 1997, 52 (06) :1157-1163

[4] Detection of HIV-1 infection with a green fluorescent protein reporter system [J].

Dorsky, DI ;

Wells, M ;

Harrington, RD .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 13 (04) :308-313

[5] THE ROLE OF TAT IN THE HUMAN-IMMUNODEFICIENCY-VIRUS LIFE-CYCLE INDICATES A PRIMARY EFFECT ON TRANSCRIPTIONAL ELONGATION [J].

FEINBERG, MB ;

BALTIMORE, D ;

FRANKEL, AD .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (09) :4045-4049

[6] FEEDBACK-REGULATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 EXPRESSION BY THE REV PROTEIN [J].

FELBER, BK ;

DRYSDALE, CM ;

PAVLAKIS, GN .

JOURNAL OF VIROLOGY, 1990, 64 (08) :3734-3741

[7] INHIBITION OF HIV REPLICATION IN ACUTE AND CHRONIC INFECTIONS INVITRO BY A TAT ANTAGONIST [J].

HSU, MC ;

SCHUTT, AD ;

HOLLY, M ;

SLICE, LW ;

SHERMAN, MI ;

RICHMAN, DD ;

POTASH, MJ ;

VOLSKY, DJ .

SCIENCE, 1991, 254 (5039) :1799-1802

[8] REGULATION OF EXPRESSION DRIVEN BY HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 AND HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I LONG TERMINAL REPEATS IN PLURIPOTENTIAL HUMAN-EMBRYONIC CELLS [J].

MAIO, JJ ;

BROWN, FL .

JOURNAL OF VIROLOGY, 1988, 62 (04) :1398-1407

[9] P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro [J].

Mancebo, HSY ;

Lee, G ;

Flygare, J ;

Tomassini, J ;

Luu, P ;

Zhu, YR ;

Peno, JM ;

Blau, C ;

Hazuda, D ;

Price, D ;

Flores, O .

GENES & DEVELOPMENT, 1997, 11 (20) :2633-2644

[10] THE LOCATION OF CIS-ACTING REGULATORY SEQUENCES IN THE HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-III (HTLV-III/LAV) LONG TERMINAL REPEAT [J].

ROSEN, CA ;

SODROSKI, JG ;

HASELTINE, WA .

CELL, 1985, 41 (03) :813-823

← 1 2 →